Repligen Corporation
Edit Page
Report
Scan day: 12 February 2014 UTC
11
Virus safety - good
Description: Researches, develops, manufactures and markets synthetic version of protein A for monoclonal antibody processing, and peptides such as secretin for gastrointestinal and pediatric neurology. Details for investors and clinical programs run from Waltham Massachusetts. (Nasdaq: RGEN)
Repligen Home Page — Repligen Corporation For serum-free proliferation and maintenance of cell lines during the fermentation stage of biologics production columns; single-use solutions for Discover Repligen's portfolio of novel diagnostic imaging and central nervous system (CNS) therapeutic product candidates available for partnering Â
Size: 346 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Repligen Home Page — Repligen Corporation |
| Keywords: | |
| Description: | |
| IP-address: | 216.119.130.194 |
WHOIS Info
| NS | Name Server: NS25.WORLDNIC.COM Name Server: NS26.WORLDNIC.COM |
| WHOIS | Status: clientTransferProhibited |
| Date | Creation Date: 10-nov-1995 Expiration Date: 09-nov-2019 |